UFP Technologies Inc. Common Stock (UFPT)
Stock · NASDAQ · Health Care
$291.67as of 10/16/2026
Price chart
Active signals
UFPT Signal Track Record
How signals performed across all stocks →What UFPT's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 30 | +3.9% | 60% | August 4, 2026 |
| Bollinger Band Breakout | 24 | +4.7% | 58% | August 4, 2026 |
| Bollinger Band Breakdown | 19 | +3.3% | 58% | April 29, 2026 |
| 200-Day Moving Average TouchActive now | 10 | +7.8% | 80% | June 1, 2026 |
| Any 20-session window (baseline) | +2.2% | 56% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About UFPT
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic imp…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 4,846
- Website
- www.ufpt.com/
Fundamentals
- 1-day range
- $287.24$297.68
- Market cap
- $2.41B
- P/E (trailing)
- 31.50
- P/E (forward)
- 24.52
- EPS (trailing)
- $9.26
- Dividend yield
- —
- Beta
- 1.10
- Avg. volume
- 146.8K
Forecasts
2 analyst ratings
UFP Technologies Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- UFPTUFP Technologies Inc. Common Stock$291.67▼ 1.86%Market cap $2.41BP/E 31.50$173.86$338.71
- HTFLHeartflow Inc. Common Stock$48.29▼ 5.14%Market cap $2.34BP/E —$20.13$54.32
- XRAYDENTSPLY SIRONA Inc. Common Stock$8.57▼ 2.94%Market cap $2.64BP/E —$8.38$14.76
- PLSEPulse Biosciences Inc Common Stock (DE)$44.43▼ 2.54%Market cap $2.65BP/E —$12.56$58.9
- ATRCAtriCure Inc. Common Stock$56.07▼ 2.96%Market cap $2.01BP/E 261.42$25.36$61.7
- LMATLeMaitre Vascular Inc. Common Stock$80.82▼ 2.81%Market cap $1.85BP/E 29.17$78.22$118.01
- NVCRNovoCure Limited Ordinary Shares$14.07▼ 2.36%Market cap $1.83BP/E —$9.82$21.45
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| UFPT UFP Technologies Inc. Common Stock | $2.41B | 31.50 | $291.67 | ▼ 1.86% | $173.86$338.71 |
| HTFL Heartflow Inc. Common Stock | $2.34B | — | $48.29 | ▼ 5.14% | $20.13$54.32 |
| XRAY DENTSPLY SIRONA Inc. Common Stock | $2.64B | — | $8.57 | ▼ 2.94% | $8.38$14.76 |
| PLSE Pulse Biosciences Inc Common Stock (DE) | $2.65B | — | $44.43 | ▼ 2.54% | $12.56$58.9 |
| ATRC AtriCure Inc. Common Stock | $2.01B | 261.42 | $56.07 | ▼ 2.96% | $25.36$61.7 |
| LMAT LeMaitre Vascular Inc. Common Stock | $1.85B | 29.17 | $80.82 | ▼ 2.81% | $78.22$118.01 |
| NVCR NovoCure Limited Ordinary Shares | $1.83B | — | $14.07 | ▼ 2.36% | $9.82$21.45 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 8.54M
- Total value held
- $1.54B
- Institutional holders
- 264
- Unknown1.10M
- Unknown777.3K
- Unknown523.4K
- Unknown326.7K
- Unknown317.1K
- Unknown303.3K
- Unknown300.6K
- Unknown246.5K
- Unknown237.3K
- Unknown227.3K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
UFP Technologies Reports Q2 Earnings
UFP Technologies released its Q2 earnings on the drug development inputs and services segment. The company’s performance was summarized in a Yahoo earnings roundup. The release provides updated financial results for the quarter. Investors can review the details to assess the company’s recent performance.
UFP Technologies Reports Q2 Earnings. UFP Technologies released its Q2 earnings on the drug development inputs and services segment. The company’s performance was summarized in a Yahoo earnings roundup. The release provides updated financial results for the quarter. Investors can review the details to assess the company’s recent performance.